Journal
JOURNAL OF PERSONALIZED MEDICINE
Volume 11, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/jpm11050391
Keywords
COVID-19; HRCT; artificial intelligence; ground glass
Funding
- National Center for Research and Development CRACoV-HHS project [SZPITALE-JEDNOIMIENNE/18/2020]
Ask authors/readers for more resources
This study compared automatic assessment of HRCT chest images by artificial intelligence in patients with pneumonia subgroups: COVID-19, bronchopneumonia, and atypical pneumonia. Significant differences were found in inflammation volume and ground glass percentage among the subgroups. However, there was partial overlap between COVID-19 pneumonia and atypical pneumonia, potentially limiting the usefulness of automatic analysis in differentiating the etiology.
The aim of this study was to compare the results of automatic assessment of high resolution computed tomography (HRCT) by artificial intelligence (AI) in 150 patients from three subgroups: pneumonia in the course of COVID-19, bronchopneumonia and atypical pneumonia. The volume percentage of inflammation and the volume percentage of ground glass were significantly higher in the atypical (respectively, 11.04%, 8.61%) and the COVID-19 (12.41%, 10.41%) subgroups compared to the bronchopneumonia (5.12%, 3.42%) subgroup. The volume percentage of consolidation was significantly higher in the COVID-19 (2.95%) subgroup compared to the atypical (1.26%) subgroup. The percentage of ground glass in the volume of inflammation was significantly higher in the atypical (89.85%) subgroup compared to the COVID-19 (79.06%) subgroup, which in turn was significantly higher compared to the bronchopneumonia (68.26%) subgroup. HRCT chest images, analyzed automatically by artificial intelligence software, taking into account the structure including ground glass and consolidation, significantly differ in three subgroups: COVID-19 pneumonia, bronchopneumonia and atypical pneumonia. However, the partial overlap, particularly between COVID-19 pneumonia and atypical pneumonia, may limit the usefulness of automatic analysis in differentiating the etiology. In our future research, we plan to use artificial intelligence for objective assessment of the dynamics of pulmonary lesions during COVID-19 pneumonia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available